CoChat
Sign Up
Cited by 241Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal

Sacks, Frank M., Campos, Hannia·2003·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2003-030636
Open this paper in CoChat — free account

Abstract

The major lipoprotein types, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), are composed of many subgroups (1–3). Classifications are based on size (1), density, or apolipoprotein (apo) content (2), or a combination of these (3), and the subfractions that are isolated have distinct metabolic and other functional properties. Thus, it is entirely reasonable to think that subfractions of the major lipoproteins have diverse relationships to coronary heart disease (CHD). Because the classical lipid risk factors by no means perfectly predict CHD in patients, lipoprotein subfractionation has the potential to improve risk prediction. Among the various lipoprotein subfractionation systems, LDL size and density by far have attracted the most basic, clinical, and population research. Several companies offer LDL size measurements to physicians as a diagnostic test for CHD risk. Several lines of evidence implicate small, dense LDL in the etiology of CHD. Small, dense LDL is often increased in relative proportion or concentration in patients with CHD. Small, dense LDL has several characteristics that are linked to atherogenesis: long residence time in plasma, and enhanced oxidizability, arterial proteoglycan binding, and permeability through the endothelial barrier (4). Together, these findings have led to the hypothesis that small, dense LDL is a potent atherogenic lipoprotein that can be used to improve risk prediction, and evaluate response to lipid therapy (5–7). Furthermore, small, dense LDL is often part of a group of high-risk characteristics including high triglycerides, low HDL, diabetes, insulin resistance, obesity, and the metabolic syndrome (8–10). This has led logically to the concept that it contributes to the high rate of CHD in these groups. Yet, the very association between small, dense LDL and these other high-risk conditions challenges proponents of the hypothesis to show a direct, independent relationship between small, dense LDL and CHD. In this article, we evaluate evidence on LDL subclasses in risk assessment and therapy, reaching the conclusion that LDL subclass measurement does not add independent information to that conferred generically by the LDL concentration along with the other standard risk factors.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2003-030636

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 88 references

Cited by

Sorted by citations

Items 201–240 of 240

Related

See all

Metadata

Authors
Sacks, F. M., & Campos, H.
Affiliations
Harvard University (US)
Corresponding author
Sacks, Frank M.
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2003-10
Volume
88
Issue
10
Pages
4525-4532
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2003-030636
OpenAlex
W2164346577
Cited by
241
References
88
Citations by year
2026: 3 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 14 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 10
FWCI
9.91
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
small dense LDL, LDL subclasses, coronary artery disease, cardiovascular risk prediction, atherogenesis, metabolic syndrome, HDL cholesterol, triglycerides
MeSH terms
Cardiovascular Diseases, Humans, Cholesterol, LDL, Particle Size

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review